Copyright © 1993 by the European Society of Cardiology.
© 1993 The European Society of Cardiology
Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy
Clinic of Medicine and Department of Clinical Sciences, University of Tampere, Tampere Finland and Cardiovascular Research Institute Maastricht (CARIM) Maastricht, The Netherlands
Received 28 September 1992; revised 21 January 1992; .
Correspondence: Karl Pietilä, MD, Clinic of Medicine, Tampere University Hospital and Department of Clinical Sciences, University of Tampere, PO Box 607, SF 33101 Tampere, Finland
Abstract
Serum C-reactive protein rises in acute myocardial infarction, correlating positively with infarct size if thrombolytic treatment is not given. This correlation disappears if thrombolytic treatment is given, although the serum C-reactive protein concentration is still associated with the clinical outcome of the patient.
We studied the effect of early coronary recanalization induced by thrombolytic treatment alone or combined with coronary angioplasty on the infarct related rise in serum C-reactive protein concentration.
The C-reactive protein response caused by the myocardial infarct was lower in patients with an open infarct-related coronary artery than in patients with a closed infarct-related coronary artery, or in control patients who did not receive thrombolytic therapy. In control patients we found the expected strong positive correlation between infarct size and serum C-reactive protein (r = 0.58; P <0.001, n = 48), which was similar to that in patients with a closed infarct-related coronary artery (r = 0.62; P <0.001, n = 17). In patients with an open infarct-related coronary artery the correlation between infarct size and serum C-reactive protein was much weaker (r = 30; P < 0.00l, n=91). Consequently infarct size explained approximately 35% of the variation in serum C-reactive protein values in the control patients and 36% in the patients with a closed infarct-related coronary artery, but only 9% of the variation in the patients with an open infarct-related artery. Ejection fraction correlated negatively with serum C-reactive protein in both control and recanalized patients. The association was again much stronger in the control patients. Ejection fraction explained 27% (28% if only first infarctions were considered) of the variation in serum C-reactive protein in the control patients and 8% (6%) in the recanalized patients.
The present results show that coronary recanalization variably reduces the infarct-associated rise in serum C-reactive protein. This explains the weaker association between serum C-reactive protein and infarct size in the patients receiving thrombolytic treatment when compared to those treated without thrombolytic drugs and may have clinical implications.
Key Words: Myocardial infarction • thrombolytic treatment • reperfusion • C-reactive protein
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Van De Graaff, M. Dutta, P. Das, E. A. Shry, P. D. Frederick, M. Blaney, D. J. Pasta, and S. R. Steinhubl Early Coronary Revascularization Diminishes the Risk of Ischemic Stroke With Acute Myocardial Infarction Stroke, October 1, 2006; 37(10): 2546 - 2551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ziakas, S. Gavrilidis, G. Giannoglou, E. Souliou, K. Gemitzis, D. Kalampalika, M. A. Vayona, I. Pidonia, G. Parharidis, and G. Louridas In-Hospital and Long-Term Prognostic Value of Fibrinogen, CRP, and IL-6 Levels in Patients with Acute Myocardial Infarction Treated with Thrombolysis Angiology, May 1, 2006; 57(3): 283 - 293. [Abstract] [PDF]
|
|
|
|
 |
|
 S.-p. Zhao, P. Deng, H.-g. Huang, Z.-m. Xu, H.-y. Dai, S.-c. Hong, J. Yang, and H.-n. Zhou Expression of COX-2 mRNA in Peripheral Blood Monocytes from Patients with Acute Myocardial Infarction and Its Significance Clin. Chem., November 1, 2005; 51(11): 2170 - 2173. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Theroux, P. W. Armstrong, K. W. Mahaffey, J. S. Hochman, K. J. Malloy, S. Rollins, J. C. Nicolau, J. Lavoie, T. M. Luong, J. Burchenal, et al. Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial Eur. Heart J., October 1, 2005; 26(19): 1964 - 1970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Z.H. Rittersma, R. J. de Winter, K. T. Koch, C. E. Schotborgh, M. Bax, G. S. Heyde, J. P. van Straalen, K. J. Mulder, J. G.P. Tijssen, G. T. Sanders, et al. Preprocedural C-Reactive Protein Is Not Associated with Angiographic Restenosis or Target Lesion Revascularization after Coronary Artery Stent Placement Clin. Chem., September 1, 2004; 50(9): 1589 - 1596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Chaudhuri, D. Janicke, M. F. Wilson, D. Tripathy, R. Garg, A. Bandyopadhyay, J. Calieri, D. Hoffmeyer, T. Syed, H. Ghanim, et al. Anti-Inflammatory and Profibrinolytic Effect of Insulin in Acute ST-Segment-Elevation Myocardial Infarction Circulation, February 24, 2004; 109(7): 849 - 854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Zimmerman, C. H. Selzman, C. Cothren, A. C. Sorensen, C. D. Raeburn, and A. H. Harken Diagnostic Implications of C-Reactive Protein Arch Surg, February 1, 2003; 138(2): 220 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.J. de Winter, G.S. Heyde, K.T. Koch, J. Fischer, J.P. van Straalen, M. Bax, C.E. Schotborgh, K.J. Mulder, G.T. Sanders, J.J. Piek, et al. The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty Eur. Heart J., June 2, 2002; 23(12): 960 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. GENCO, S. OFFENBACHER, and J. BECK Periodontal disease and cardiovascular disease: Epidemiology and possible mechanisms J Am Dent Assoc, June 1, 2002; 133(suppl_1): 14S - 22S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. S. Rost, P. A. Wolf, C. S. Kase, M. Kelly-Hayes, H. Silbershatz, J. M. Massaro, R. B. D'Agostino, C. Franzblau, and P. W.F. Wilson Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Study Stroke, November 1, 2001; 32(11): 2575 - 2579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Muhlestein, B. D. Horne, J. F. Carlquist, T. E. Madsen, T. L. Bair, R. R. Pearson, and J. L. Anderson Cytomegalovirus Seropositivity and C-Reactive Protein Have Independent and Combined Predictive Value for Mortality in Patients With Angiographically Demonstrated Coronary Artery Disease Circulation, October 17, 2000; 102(16): 1917 - 1923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Garcia-Moll, E. Zouridakis, D. Cole, and J.C. Kaski C-reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men Eur. Heart J., October 1, 2000; 21(19): 1598 - 1606. [Abstract] [PDF]
|
|
|
|
|
|
R. J. de Winter, J. Fischer, R. Bholasingh, J. P. van Straalen, T. de Jong, J. G.P. Tijssen, and G. T. Sanders C-Reactive Protein and Cardiac Troponin T in Risk Stratification: Differences in Optimal Timing of Tests Early after the Onset of Chest Pain Clin. Chem., October 1, 2000; 46(10): 1597 - 1603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Epstein, J. Zhu, M. S. Burnett, Y. F. Zhou, G. Vercellotti, and D. Hajjar Infection and Atherosclerosis : Potential Roles of Pathogen Burden and Molecular Mimicry Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1417 - 1420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhu, A. A. Quyyumi, J. E. Norman, G. Csako, and S. E. Epstein Cytomegalovirus in the pathogenesis of atherosclerosis: The role of inflammation as reflected by elevated C-reactive protein levels J. Am. Coll. Cardiol., November 15, 1999; 34(6): 1738 - 1743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Epstein, Y. F. Zhou, and J. Zhu Infection and Atherosclerosis : Emerging Mechanistic Paradigms Circulation, July 27, 1999; 100 (4): e20 - e28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. K. Lagrand, C. A. Visser, W. T. Hermens, H. W. M. Niessen, F. W. A. Verheugt, G.-J. Wolbink, and C. E. Hack C-Reactive Protein as a Cardiovascular Risk Factor : More Than an Epiphenomenon? Circulation, July 6, 1999; 100(1): 96 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Boeken, P. Feindt, N. Zimmermann, G. Kalweit, T. Petzold, and E. Gams Increased preoperative C-reactive protein (CRP)-values without signs of an infection and complicated course after cardiopulmonary bypass (CPB) - operations Eur. J. Cardiothorac. Surg., May 1, 1999; 13(5): 541 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Anderson, J. F. Carlquist, J. B. Muhlestein, B. D. Horne, and S. P. Elmer Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction J. Am. Coll. Cardiol., July 1, 1998; 32(1): 35 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J de Winter, A. Manten, Y. P de Jong, R. Adams, S. J H van Deventer, and K. I Lie Interleukin 8 released after acute myocardial infarction is mainly bound to erythrocytes Heart, December 1, 1997; 78(6): 598 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Ridker, M. Cushman, M. J. Stampfer, R. P. Tracy, and C. H. Hennekens Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men N. Engl. J. Med., April 3, 1997; 336(14): 973 - 979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. K. Lagrand, H. W.M. Niessen, G.-J. Wolbink, L. H. Jaspars, C. A. Visser, F. W.A. Verheugt, C. J.L.M. Meijer, and C. E. Hack C-Reactive Protein Colocalizes With Complement in Human Hearts During Acute Myocardial Infarction Circulation, January 7, 1997; 95(1): 97 - 103. [Abstract] [Full Text]
|
|